Scientists
have long known that some drugs, such as heroin and morphine, can cause
changes in the immune systems of drug abusers that make them more susceptible
to infection. However, Dr. Donald Lysle and Stephanie Ijames from the
University of North Carolina at Chapel Hill have now found that in rats,
the environmental cues associated with drug use also may induce alterations
in immunity. Their study is the first to demonstrate that cues associated
with heroin use cause a reduction in the enzyme, inducible nitric oxide
synthase (iNOS), which affects nitric oxide production by cells of the
immune system. Nitric oxide plays a key role in the ability of immune
cells to fight and kill microorganisms and tumor cells.
The researchers
conditioned male rats to associate heroin administration with placement
in a new environment by administering the drug to the rats as soon as
they were placed in that environment. On the test day, the rats were
re-exposed to the environment in the absence of heroin and then given
an injection of lipopolysaccharide (LPS), which induces iNOS production
by immune cells. Six hours later, the rats' spleens, lungs, and livers
were analyzed for the expression of iNOS messenger ribonucleic acid
(mRNA) and iNOS protein. Control groups were used to determine if any
step in the conditioning process, such as the injection procedure, reexposure
to the conditioning environment, or a combination of injection of heroin
and exposure to the environment, contributed to alterations in iNOS
production. The researchers also used an unmanipulated control group
to provide a general comparison for all the control groups, as well
as the experimental group.
|
|
The
researchers found that exposure to the environmental cues associated
with heroin administration resulted in a dramatic reduction in the expression
of iNOS mRNA and iNOS protein in the conditioned rats' spleen, lung,
and liver tissues.
What it means: These findings suggest that environmental cues
associated with drug use may contribute to alterations in susceptibility
to infection. This study, funded by the National Institute on Drug Abuse,
was published in the December 2002 issue of Psychopharmacology.
NIDA NewsScan,
April 9, 2003 |